1. Home
  2. ADMA vs CGNX Comparison

ADMA vs CGNX Comparison

Compare ADMA & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CGNX
  • Stock Information
  • Founded
  • ADMA 2004
  • CGNX 1981
  • Country
  • ADMA United States
  • CGNX United States
  • Employees
  • ADMA N/A
  • CGNX N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CGNX Industrial Machinery/Components
  • Sector
  • ADMA Health Care
  • CGNX Industrials
  • Exchange
  • ADMA Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • ADMA 5.1B
  • CGNX 5.7B
  • IPO Year
  • ADMA N/A
  • CGNX 1989
  • Fundamental
  • Price
  • ADMA $17.80
  • CGNX $44.79
  • Analyst Decision
  • ADMA Strong Buy
  • CGNX Buy
  • Analyst Count
  • ADMA 3
  • CGNX 10
  • Target Price
  • ADMA $27.67
  • CGNX $42.20
  • AVG Volume (30 Days)
  • ADMA 3.3M
  • CGNX 2.4M
  • Earning Date
  • ADMA 08-06-2025
  • CGNX 07-30-2025
  • Dividend Yield
  • ADMA N/A
  • CGNX 0.71%
  • EPS Growth
  • ADMA 469.09
  • CGNX 59.92
  • EPS
  • ADMA 0.85
  • CGNX 0.72
  • Revenue
  • ADMA $474,174,000.00
  • CGNX $929,555,000.00
  • Revenue This Year
  • ADMA $21.11
  • CGNX $6.36
  • Revenue Next Year
  • ADMA $25.97
  • CGNX $10.31
  • P/E Ratio
  • ADMA $20.93
  • CGNX $62.37
  • Revenue Growth
  • ADMA 43.58
  • CGNX 10.14
  • 52 Week Low
  • ADMA $13.50
  • CGNX $22.67
  • 52 Week High
  • ADMA $25.67
  • CGNX $44.85
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 51.09
  • CGNX 72.12
  • Support Level
  • ADMA $16.93
  • CGNX $41.89
  • Resistance Level
  • ADMA $17.90
  • CGNX $43.83
  • Average True Range (ATR)
  • ADMA 0.86
  • CGNX 1.18
  • MACD
  • ADMA 0.04
  • CGNX -0.02
  • Stochastic Oscillator
  • ADMA 59.11
  • CGNX 98.25

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: